TNF Pharmaceuticals, Inc. (TNFA) Analysis

TNF Pharmaceuticals (TNFA) announced that data from the Phase 2a clinical trial of its oral TNF-alpha inhibitor drug candidate isomyosamine was presented last week in a podium session at the peer-reviewed 15th International Conference on Frailty and Sarcopenia Research held March 12-14, in Toulouse, France. The presentation included Phase 2a clinical data showing decreases of biomarkers associated with TNF-a activation in elderly patients with sarcopenia. The company’s recently initiated Phase 2

$TNFAThis Ain’t Just a Ticker — It’s a Ticking Bio Bomb 💣🧬 🧠 Micro float (~14M) 🔥 18% short interest 💸 Trading under $0.13 🧪 Clinical-stage biotech with PHASE 2B on deck 🧬 Targeting inflammation, sarcopenia, and rare disease via TNF-α inhibition 🧃 Market cap: $1.6M — I’ve seen bigger meme coins Why am I in? Because if they announce Phase 2B enrollment, or drop good trial results, this goes from penny dust to rocket fuel. 🎯 My strategy: • Buy at $0.11–$0.12 • HODL for $0.18–$0.25 • Mentally...

Why I think TNFA will go to $1 in coming days? Reasons: 1. Novel Drug Platform TNFA is developing Isomyosamine (MYMD‑1) — an oral TNF-α inhibitor aimed at chronic inflammation, muscle loss in aging, and weight-loss drug side effects (e.g. Ozempic-induced frailty). It’s a potentially safer, cheaper alternative to current injectable biologics. 2. Targeting Big Markets • Sarcopenia (muscle loss), rheumatoid arthritis, and frailty are billion-dollar markets. • New focus: GLP‑1 users (Wegovy/Oz...

I came across someone in StockTwits posting the short stats for $TNFA and it seemed odd. Keep in mind, I’m not 100% sure of all the technicalities behind shorting, so none of this may be right. Please let me know what you think. I am pretty lost with what to think of this information. 1. The first and second images shows an “off-exchange short volume” of about 50 million shares. This doesn’t make much sense to me, because there are only about 14 million shares outstanding total. Am I missing so...

Thoughts on $TNFA, only bought into a small position of 1000 shares for the fun of it.